How Much Did Novilytic Raise?
Funding & Key Investors

Novilytic has successfully secured a significant capital infusion, bringing its total funding to $1.7M. This latest injection of resources, totaling $1.6M, marks a pivotal moment for the molecular recognition firm as it transitions from early-stage development into a more robust enterprise-level operational phase. The strategic investment underscores the growing market confidence in the company's proprietary nanotechnology platform, which is designed to revolutionize the quality control processes for critical, lifesaving pharmaceutical products.

What is Novilytic?

Novilytic
Business ServicesResearch & Development

Novilytic operates at the intersection of biotechnology and advanced materials science, specializing in molecular recognition technology. By leveraging nanotechnology, the company provides high-precision monitoring solutions that ensure the integrity and efficacy of complex medicines. This technological edge positions Novilytic as a vital player in the pharmaceutical supply chain, addressing the industry's urgent need for real-time, accurate quality assurance. As the firm scales, its focus remains on mitigating risks associated with drug manufacturing and distribution, thereby safeguarding patient outcomes through superior analytical capabilities.

How much funding has Novilytic raised?

Novilytic has raised a total of $1.7M across 2 funding rounds:

2021

Debt

$54K

2022

Angel/Seed

$1.6M

Debt (2021): $54K with participation from PPP

Angel/Seed (2022): $1.6M led by Elevate Ventures and Purdue Foundry

Key Investors in Novilytic

Elevate Ventures

Elevate Ventures is an active participant in shaping the future of Indiana by investing in cross-sector innovation-driven companies at Pre-Seed, Seed, and Series A stages.

Purdue Foundry

Purdue Foundry is an entrepreneurship and commercialization hub that supports startups by providing resources, mentorship, and access to capital for university-affiliated ventures.

PPP

Public-Private Partnership

What's next for Novilytic?

With this major strategic investment, Novilytic is well-positioned to accelerate its commercialization roadmap and expand its footprint within the global life sciences sector. The company is expected to prioritize the scaling of its manufacturing capabilities and the deepening of its R&D initiatives to address broader therapeutic categories. By strengthening its market position, Novilytic aims to establish its nanotechnology-driven monitoring as the gold standard for pharmaceutical quality control. Future growth will likely hinge on strategic partnerships with major pharmaceutical manufacturers and the continued validation of its platform across diverse regulatory environments, ensuring long-term sustainability and industry-wide adoption.

See full Novilytic company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Business Services industry

Business ServicesCommercial Printing
Business ServicesSoftware Testing
Business ServicesProject Management
Business ServicesProject Management

Frequently Asked Questions Regarding Novilytic Financial Insights

What are the most recent funding rounds that Novilytic has completed, and what were the funding rounds?
Novilytic has recently completed 2 funding rounds: Angel/Seed on May 3, 2022, Debt on Feb 13, 2021.
What is the total amount of funding Novilytic has raised to date?
Novilytic has raised a total of $1.7M in funding to date.
How many funding rounds has Novilytic completed?
Novilytic has completed 2 funding rounds.
How much funding did Novilytic raise in its most recent funding round?
Novilytic raised $1.6M in its most recent funding round.
Who are the lead investors in Novilytic's latest funding round?
The lead investor in Novilytic's latest funding round was Elevate Ventures. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Novilytic's history?
The largest funding round in Novilytic's history was $1.6M.
See more information about Novilytic